Br J Rheumatol. 1988 Aug;27(4):281-5.

Elevated von Willebrand factor antigen in systemic sclerosis: relationship to visceral disease.

Greaves M, Malia RG, Milford Ward A, Moult J, Holt CM, Lindsey N, Hughes P, Goodfield M, Rowell NR.

Source

Department of Haematology, Royal Hallamshire Hospital, Leeds.

Abstract

Plasma levels of the factor VIII complex (von Willebrand factor antigen, factor VIII coagulant and ristocetin co-factor) were measured in 28 patients with systemic sclerosis. Elevated von Willebrand factor antigen was found in 12 patients overall and in 10 of 16 patients characterized by severe extensive visceral disease, with a resulting positive correlation between the extent of visceral involvement and the plasma level of von Willebrand factor antigen (r = 0.60, p less than 0.001). Factor VIII coagulant and ristocetin co-factor levels, however, frequently failed to parallel the increases of von Willebrand factor antigen, supporting the view that these increases were due to in vivo endothelial damage. The findings suggest that vascular damage is an important aspect of the visceral lesions of systemic sclerosis.

PMID:: 3136816; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances, Grant Support

Publication Types

Research Support, Non-U.S. Gov't

MeSH Terms

Substances

Grant Support

Wellcome Trust/United Kingdom

LinkOut - more resources

Full Text Sources

HighWire Press - PDF

Medical

Libraries

LinkOut Holdings

Supplemental Content

Save items

Related citations in PubMed

Increased factor VIII/von Willebrand factor antigen and von Willebrand factor activity in scleroderma and in Raynaud's phenomenon. [Ann Intern Med. 1981]
Increased factor VIII/von Willebrand factor antigen and von Willebrand factor activity in scleroderma and in Raynaud's phenomenon.
Kahaleh MB, Osborn I, LeRoy EC. Ann Intern Med. 1981 Apr; 94(4 pt 1):482-4.
Factor VIII-von Willebrand factor in giant cell arteritis and polymyalgia rheumatica. [Mayo Clin Proc. 1985]
Factor VIII-von Willebrand factor in giant cell arteritis and polymyalgia rheumatica.
Persellin ST, Daniels TM, Rings LJ, Kazmier FJ, Bowie EJ, Hunder GG. Mayo Clin Proc. 1985 Jul; 60(7):457-62.
Changes in the factor VIII complex in diabetic ketoacidosis: evidence of endothelial cell damage? [Diabetologia. 1987]
Changes in the factor VIII complex in diabetic ketoacidosis: evidence of endothelial cell damage?
Greaves M, Pickering C, Knight G, Boulton AJ, Ball J, Ward JD, Preston FE. Diabetologia. 1987 Mar; 30(3):160-5.
Review von Willebrand factor antigen is an independent marker of poor outcome in patients with early acute lung injury. [Crit Care Med. 2001]
Review von Willebrand factor antigen is an independent marker of poor outcome in patients with early acute lung injury.
Ware LB, Conner ER, Matthay MA. Crit Care Med. 2001 Dec; 29(12):2325-31.
Review Acquired von Willebrand syndromes: clinical features, aetiology, pathophysiology, classification and management. [Best Pract Res Clin Haematol. ...]
Review Acquired von Willebrand syndromes: clinical features, aetiology, pathophysiology, classification and management.
Michiels JJ, Budde U, van der Planken M, van Vliet HH, Schroyens W, Berneman Z. Best Pract Res Clin Haematol. 2001 Jun; 14(2):401-36.

See reviews... See all...

Cited by 7 PubMed Central articles

Vascular involvement in systemic sclerosis (scleroderma). [J Inflamm Res. 2011]
Vascular involvement in systemic sclerosis (scleroderma).
Pattanaik D, Brown M, Postlethwaite AE. J Inflamm Res. 2011; 4:105-25. Epub 2011 Jul 26.
Protective effect of pravastatin on vascular endothelium in patients with systemic sclerosis: a pilot study. [Ann Rheum Dis. 2006]
Protective effect of pravastatin on vascular endothelium in patients with systemic sclerosis: a pilot study.
Furukawa S, Yasuda S, Amengual O, Horita T, Atsumi T, Koike T. Ann Rheum Dis. 2006 Aug; 65(8):1118-20.
Von Willebrand factor propeptide as a marker of disease activity in systemic sclerosis (scleroderma). [Arthritis Res. 2001]
Von Willebrand factor propeptide as a marker of disease activity in systemic sclerosis (scleroderma).
Scheja A, Akesson A, Geborek P, Wildt M, Wollheim CB, Wollheim FA, Vischer UM. Arthritis Res. 2001; 3(3):178-82. Epub 2001 Feb 19.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Elevated von Willebrand factor antigen in systemic sclerosis: relationship to vi...
Elevated von Willebrand factor antigen in systemic sclerosis: relationship to visceral disease.
Br J Rheumatol. 1988 Aug ;27(4):281-5.

PubMed
Prevalence and incidence of the diagnosis of gout in Great Britain.
Prevalence and incidence of the diagnosis of gout in Great Britain.
Ann Rheum Dis. 1979 Apr ;38(2):101-6.

PubMed
Effects of interleukin-1 and arachidonate on the preoptic and anterior hypothala...
Effects of interleukin-1 and arachidonate on the preoptic and anterior hypothalamic neurons.
Brain Res Bull. 1988 Jan ;20(1):75-82.

PubMed
Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifes...
Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains.
J Exp Med. 1978 Nov 1 ;148(5):1198-215.

PubMed
Factor VIII complex in progressive systemic sclerosis.
Factor VIII complex in progressive systemic sclerosis.
Clin Exp Rheumatol. 1986 Oct-Dec ;4(4):319-21.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: